{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:16:12Z","timestamp":1778692572545,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["SES-1461470"],"award-info":[{"award-number":["SES-1461470"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["GRANT NUMBER SES-1461470"],"award-info":[{"award-number":["GRANT NUMBER SES-1461470"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.drugalcdep.2019.107743","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T12:09:13Z","timestamp":1574251753000},"page":"107743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Understanding disparities in access to naloxone among people who inject drugs in Southeast Michigan using respondent driven sampling"],"prefix":"10.1016","volume":"206","author":[{"given":"Ai Rene","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Bonar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107743_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107581","article-title":"Take-home naloxone possession among people who inject drugs in rural West Virginia","volume":"204","author":"Allen","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08897077.2016.1184739","article-title":"Opioid overdose prevention through pharmacy-based naloxone prescription program: innovations in health care delivery","volume":"38","author":"Bachyrycz","year":"2017","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0020","series-title":"National HIV Behavioral Surveillance System Round 4: Model Surveillance Protocol","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0025","series-title":"U.S. Drug Overdose Deaths Continue to Rise; Increase Fueled by Synthetic Opioids","author":"Center for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0035","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","article-title":"Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities","volume":"105","author":"Faul","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0040","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists\u2019 role in opioid overdose: Kentucky\u2019s pharmacists in willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2018.04.020","article-title":"State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies","volume":"189","author":"Xu","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2016.303062","article-title":"Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013","volume":"106","author":"Jones","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0060","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ajem.2018.03.066","article-title":"Naloxone access among an urban population of opioid users","volume":"36","author":"Nikolaides","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0065","series-title":"Naloxone","author":"Michigan Department of Health and Human Services","year":"2014"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drugpo.2019.07.010","article-title":"Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs","volume":"73","author":"Reed","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","article-title":"Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade","volume":"59","author":"Tobin","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0080","first-page":"79","article-title":"Probability based estimation theory for respondent driven sampling","volume":"24","author":"Volz","year":"2008","journal-title":"J. Off. Stat."},{"key":"10.1016\/j.drugalcdep.2019.107743_bib0085","series-title":"Naloxone: A Take Home Antidote to Drug Overdose That Saves Lives","author":"World Health Organization","year":"2014"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:39:42Z","timestamp":1778690382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619305204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"alternative-id":["S0376871619305204"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107743","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding disparities in access to naloxone among people who inject drugs in Southeast Michigan using respondent driven sampling","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107743"}}